Search research articles
Contact Us
Filters
Showing results (1-10 of 183) with videos related to
Page
of 19
Sort By:
Lancet (London, England)
|
June 2, 1998
Conventional cancer therapy: promise broken or promise delayed?
I F Tannock
Journal of the National Cancer Institute
|
February 21, 1996
False-positive results in clinical trials: multiple significance tests and the problem of unreported comparisons
I F Tannock
Progress in Clinical and Biological Research
|
January 1, 1988
Analysis of trials using chemotherapy for metastatic bladder cancer
I F Tannock
The New England Journal of Medicine
|
January 5, 2002
Removing the primary tumor after the cancer has spread
I F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2000
Commentary on "cytoreduction nephrectomy in metastatic renal cancer: the results of Southwest Oncology Group Trial 8949"
I F Tannock
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2019
Disclosure-in the blink of an eye
I F Tannock
Hospital Practice (Office Ed.)
|
April 1, 1983
Biology and tumor growth
I F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1985
Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
I F Tannock
Cancer Metastasis Reviews
|
February 8, 2002
Tumor physiology and drug resistance
I F Tannock
Oncology (Williston Park, N.Y.)
|
May 1, 1990
Management of breast and prostate cancer: how does quality of life enter the equation?
I F Tannock
Page
of 19
Search research articles
Search
Showing results (1-10 of 183) with videos related to
Sort By:
Page
of 19
Lancet (London, England)
|
June 2, 1998
Conventional cancer therapy: promise broken or promise delayed?
I F Tannock
Journal of the National Cancer Institute
|
February 21, 1996
False-positive results in clinical trials: multiple significance tests and the problem of unreported comparisons
I F Tannock
Progress in Clinical and Biological Research
|
January 1, 1988
Analysis of trials using chemotherapy for metastatic bladder cancer
I F Tannock
The New England Journal of Medicine
|
January 5, 2002
Removing the primary tumor after the cancer has spread
I F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2000
Commentary on "cytoreduction nephrectomy in metastatic renal cancer: the results of Southwest Oncology Group Trial 8949"
I F Tannock
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2019
Disclosure-in the blink of an eye
I F Tannock
Hospital Practice (Office Ed.)
|
April 1, 1983
Biology and tumor growth
I F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1985
Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
I F Tannock
Cancer Metastasis Reviews
|
February 8, 2002
Tumor physiology and drug resistance
I F Tannock
Oncology (Williston Park, N.Y.)
|
May 1, 1990
Management of breast and prostate cancer: how does quality of life enter the equation?
I F Tannock
Page
of 19